J05AP55 - sofosbuvir and velpatasvir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
J05AB16 - remdesivir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AF13 - tenofovir alafenamide : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AF07 - tenofovir disoproxil : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AP56 - sofosbuvir, velpatasvir and voxilaprevir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
J05AP55 - sofosbuvir and velpatasvir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
J05AB16 - remdesivir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AF13 - tenofovir alafenamide : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AF07 - tenofovir disoproxil : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AP56 - sofosbuvir, velpatasvir and voxilaprevir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
J05AB16 - remdesivir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AP56 - sofosbuvir, velpatasvir and voxilaprevir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.